291 related articles for article (PubMed ID: 28866231)
1. Gardasil Vaccination for Recurrent Laryngeal Papillomatosis in Adult Men Second Report: Negative Conversion of HPV in Laryngeal Secretions.
Hirai R; Makiyama K; Matsuzaki H; Oshima T
J Voice; 2018 Jul; 32(4):488-491. PubMed ID: 28866231
[TBL] [Abstract][Full Text] [Related]
2. Gardasil Vaccination for Recurrent Laryngeal Papillomatosis in Adult Men: First Report: Changes in HPV Antibody Titer.
Makiyama K; Hirai R; Matsuzaki H
J Voice; 2017 Jan; 31(1):104-106. PubMed ID: 27068425
[TBL] [Abstract][Full Text] [Related]
3. Assessment of human papilloma virus infection in adult laryngeal papilloma using a screening test.
Makiyama K; Hirai R; Matsuzaki H; Ikeda M
J Voice; 2013 Mar; 27(2):230-5. PubMed ID: 23273988
[TBL] [Abstract][Full Text] [Related]
4. Recurrent laryngeal papillomatosis: successful treatment with human papillomavirus vaccination.
Mudry P; Vavrina M; Mazanek P; Machalova M; Litzman J; Sterba J
Arch Dis Child; 2011 May; 96(5):476-7. PubMed ID: 21220258
[TBL] [Abstract][Full Text] [Related]
5. Multi-Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis.
Matsuzaki H; Makiyama K; Hirai R; Suzuki H; Asai R; Oshima T
Laryngoscope; 2020 Feb; 130(2):442-447. PubMed ID: 30963598
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and molecular biology studies of respiratory papillomatosis].
Mahnke CG; Werner JA; Fröhlich O; Lippert BM; Hoffmann M; Rudert HH
Laryngorhinootologie; 1998 Mar; 77(3):157-64. PubMed ID: 9577823
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years.
Einstein MH; Baron M; Levin MJ; Chatterjee A; Edwards RP; Zepp F; Carletti I; Dessy FJ; Trofa AF; Schuind A; Dubin G;
Hum Vaccin; 2009 Oct; 5(10):705-19. PubMed ID: 19684472
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus in laryngeal papillomas and in adjacent normal epithelium.
Rihkanen H; Aaltonen LM; Syrjänen SM
Clin Otolaryngol Allied Sci; 1993 Dec; 18(6):470-4. PubMed ID: 8877222
[TBL] [Abstract][Full Text] [Related]
9. HPV RNA in-situ hybridization as a diagnostic aid in papillary laryngeal lesions.
Garcia JA; Best SR; Rooper LM
Laryngoscope; 2020 Apr; 130(4):955-960. PubMed ID: 31283030
[TBL] [Abstract][Full Text] [Related]
10. Poor antibody response against human papillomavirus in adult-onset laryngeal papillomatosis.
Aaltonen LM; Auvinen E; Dillner J; Lehtinen M; Paavonen J; Rihkanen H; Vaheri A
J Med Microbiol; 2001 May; 50(5):468-471. PubMed ID: 11339256
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and molecular biology studies of laryngeal papillomatosis].
Mahnke CG; Werner JA; Fröhlich O; Lippert BM; Hoffman H; Rudert HH
Laryngorhinootologie; 1998 Jan; 77(1):27-33. PubMed ID: 9522309
[TBL] [Abstract][Full Text] [Related]
12. E6 and E7 oncogene expression by human papilloma virus (HPV) and the aggressive behavior of recurrent laryngeal papillomatosis (RLP).
Shehata BM; Otto KJ; Sobol SE; Stockwell CA; Foulks C; Lancaster W; Gregoire L; Hill CE
Pediatr Dev Pathol; 2008; 11(2):118-21. PubMed ID: 17990904
[TBL] [Abstract][Full Text] [Related]
13. Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis.
Tjon Pian Gi RE; San Giorgi MR; Pawlita M; Michel A; van Hemel BM; Schuuring EM; van den Heuvel ER; van der Laan BF; Dikkers FG
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3231-6. PubMed ID: 27188508
[TBL] [Abstract][Full Text] [Related]
14. Human papilloma virus-associated squamous cell carcinoma of the larynx in an 18-year-old woman.
Hotz MA; Christen B; Sahli R; Arnold AM
Head Neck; 2019 Apr; 41(4):E59-E61. PubMed ID: 30589154
[TBL] [Abstract][Full Text] [Related]
15. Laryngeal papillomatosis associated dysplasia in the adult population: an update on prevalence and HPV subtyping.
Davids T; Muller S; Wise JC; Johns MM; Klein A
Ann Otol Rhinol Laryngol; 2014 Jun; 123(6):402-8. PubMed ID: 24690979
[TBL] [Abstract][Full Text] [Related]
16. Reliable detection of human papillomavirus in recurrent laryngeal papillomatosis and associated carcinoma of archival tissue.
Weiss D; Heinkele T; Rudack C
J Med Virol; 2015 May; 87(5):860-70. PubMed ID: 25650265
[TBL] [Abstract][Full Text] [Related]
17. Mucosal swabs detect HPV in laryngeal papillomatosis patients but not family members.
Sun JD; Weatherly RA; Koopmann CF; Carey TE
Int J Pediatr Otorhinolaryngol; 2000 Jun; 53(2):95-103. PubMed ID: 10906514
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a study on 574 tissue specimens.
Komloš KF; Kocjan BJ; Košorok P; Luzar B; Meglič L; Potočnik M; Hočevar-Boltežar I; Gale N; Seme K; Poljak M
J Med Virol; 2012 Aug; 84(8):1233-41. PubMed ID: 22711351
[TBL] [Abstract][Full Text] [Related]
19. Implementation of Routine HPV Vaccination in the Management of Recurrent Respiratory Papillomatosis.
Yiu Y; Fayson S; Smith H; Matrka L
Ann Otol Rhinol Laryngol; 2019 Apr; 128(4):309-315. PubMed ID: 30595025
[TBL] [Abstract][Full Text] [Related]
20. [Recurrent laryngeal papillomatosis].
Coordes A; Grund D; Mainka A; Olze H; Hanitsch L; von Bernuth H; Dommerich S
HNO; 2023 Feb; 71(2):77-82. PubMed ID: 36477391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
